Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Edwards

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Bioconjugate Chemistry|March 1, 1996
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugatesJ A Barrett, D J Damphousse, S J Heminway, et al.
Journal of Pharmaceutical Sciences|February 13, 2001
Towards developing a non-SnCl2 formulation for RP444, a new radiopharmaceutical for thrombus imagingS Liu, D S Edwards, A R Harris, et al.
Bioconjugate Chemistry|January 1, 1996
Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligandsS Liu, D S Edwards, R J Looby, et al.
Nuclear Medicine Communications|February 24, 2001
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbitsA H Brouwers, P Laverman, O C Boerman, et al.
Bioconjugate Chemistry|March 1, 1997
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcD S Edwards, S Liu, J A Barrett, et al.
Epidemiology and Infection|May 29, 2013
Campylobacteriosis outbreak associated with consumption of undercooked chicken liver pâté in the East of England, September 2011: identification of a dose-response riskD S Edwards, L M Milne, K Morrow, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Bioconjugate Chemistry|September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imagingD S Edwards, S Liu, M C Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammationC J van der Laken, O C Boerman, W J Oyen, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bioconjugate Chemistry|March 1, 1996
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugatesJ A Barrett, D J Damphousse, S J Heminway, et al.
Journal of Pharmaceutical Sciences|February 13, 2001
Towards developing a non-SnCl2 formulation for RP444, a new radiopharmaceutical for thrombus imagingS Liu, D S Edwards, A R Harris, et al.
Bioconjugate Chemistry|January 1, 1996
Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligandsS Liu, D S Edwards, R J Looby, et al.
Nuclear Medicine Communications|February 24, 2001
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbitsA H Brouwers, P Laverman, O C Boerman, et al.
Bioconjugate Chemistry|March 1, 1997
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcD S Edwards, S Liu, J A Barrett, et al.
Epidemiology and Infection|May 29, 2013
Campylobacteriosis outbreak associated with consumption of undercooked chicken liver pâté in the East of England, September 2011: identification of a dose-response riskD S Edwards, L M Milne, K Morrow, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Bioconjugate Chemistry|September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imagingD S Edwards, S Liu, M C Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammationC J van der Laken, O C Boerman, W J Oyen, et al.
Pageof 5